Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells

OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis.

Saved in:
Bibliographic Details
Main Authors: Zhou,Xiaohui, Liu,Jing, Yang,Siyi, Su,Yanguang, Meng,Zhipeng, Hu,Yuqin
Format: Digital revista
Language:English
Published: Faculdade de Medicina / USP 2020
Online Access:http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275
Tags: Add Tag
No Tags, Be the first to tag this record!
id oai:scielo:S1807-59322020000100275
record_format ojs
spelling oai:scielo:S1807-593220200001002752020-09-09Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cellsZhou,XiaohuiLiu,JingYang,SiyiSu,YanguangMeng,ZhipengHu,Yuqin Hypoxia Ketamine p66Shc Sirt1 OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis.info:eu-repo/semantics/openAccessFaculdade de Medicina / USPClinics v.75 20202020-01-01info:eu-repo/semantics/articletext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275en10.6061/clinics/2020/e1865
institution SCIELO
collection OJS
country Brasil
countrycode BR
component Revista
access En linea
databasecode rev-scielo-br
tag revista
region America del Sur
libraryname SciELO
language English
format Digital
author Zhou,Xiaohui
Liu,Jing
Yang,Siyi
Su,Yanguang
Meng,Zhipeng
Hu,Yuqin
spellingShingle Zhou,Xiaohui
Liu,Jing
Yang,Siyi
Su,Yanguang
Meng,Zhipeng
Hu,Yuqin
Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
author_facet Zhou,Xiaohui
Liu,Jing
Yang,Siyi
Su,Yanguang
Meng,Zhipeng
Hu,Yuqin
author_sort Zhou,Xiaohui
title Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
title_short Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
title_full Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
title_fullStr Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
title_full_unstemmed Ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
title_sort ketamine ameliorates hypoxia-induced endothelial injury in human umbilical vein endothelial cells
description OBJECTIVES: Hypoxia leads to endothelial cell inflammation, apoptosis, and damage, which plays an important role in the complications associated with ischemic cardiovascular disease. As an oxidoreductase, p66Shc plays an important role in the regulation of reactive oxygen species (ROS) production and apoptosis. Ketamine is widely used in clinics. This study was designed to assess the potential protective effect of ketamine against hypoxia-induced injury in human umbilical vein endothelial cells (HUVECs). Moreover, we explored the potential mechanism by which ketamine protected against hypoxia-induced endothelial injury. METHODS: The protective effects of ketamine against hypoxia-induced injury was assessed using cell viability and adhesion assays, quantitative polymerase chain reaction, and western blotting. RESULTS: Our data showed that hypoxia reduced HUVEC viability, increased the adhesion between HUVECs and monocytes, and upregulated the expression of endothelial adhesion molecules at the protein and mRNA levels. Moreover, hypoxia increased ROS accumulation and upregulated p66Shc expression. Furthermore, hypoxia downregulated sirt1 expression in HUVECs. Alternatively, ketamine was shown to reverse the hypoxia-mediated reduction of cell viability and increase in the adhesion between HUVECs and monocytes, ameliorate hypoxia-induced ROS accumulation, and suppress p66Shc expression. Moreover, EX527, a sirt1 inhibitor, reversed the protective effects of ketamine against the hypoxia-mediated reduction of cell viability and increase in adhesion between HUVECs and monocytes. CONCLUSION: Ketamine reduces hypoxia-induced p66Shc expression and attenuates ROS accumulation via upregulating sirt1 in HUVECs, thus attenuating hypoxia-induced endothelial cell inflammation and apoptosis.
publisher Faculdade de Medicina / USP
publishDate 2020
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1807-59322020000100275
work_keys_str_mv AT zhouxiaohui ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
AT liujing ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
AT yangsiyi ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
AT suyanguang ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
AT mengzhipeng ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
AT huyuqin ketamineameliorateshypoxiainducedendothelialinjuryinhumanumbilicalveinendothelialcells
_version_ 1756432356892213248